213 related articles for article (PubMed ID: 27015541)
1. Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage.
Hwang DE; Ryou JH; Oh JR; Han JW; Park TK; Kim HS
PLoS One; 2016; 11(3):e0152522. PubMed ID: 27015541
[TBL] [Abstract][Full Text] [Related]
2. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
Ferrara N; Damico L; Shams N; Lowman H; Kim R
Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
[TBL] [Abstract][Full Text] [Related]
3. Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration.
Wang WQ; Wang FH; Qin WX; Liu HY; Lu B; Chung C; Zhu J; Gu Q; Shi W; Wen C; Wu F; Zhang K; Sun XD
Mol Pharm; 2016 Sep; 13(9):2881-90. PubMed ID: 27089240
[TBL] [Abstract][Full Text] [Related]
4. Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration.
Kim SH; Kim H; Ku HJ; Park JH; Cha H; Lee S; Lee JH; Park JW
Redox Biol; 2016 Dec; 10():211-220. PubMed ID: 27810736
[TBL] [Abstract][Full Text] [Related]
5. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
6. VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.
Jo DH; Kim S; Kim D; Kim JH; Jon S; Kim JH
Biomaterials; 2014 Mar; 35(9):3052-9. PubMed ID: 24388818
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
Emerson MV; Lauer AK
BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
[TBL] [Abstract][Full Text] [Related]
9. miRNA involvement in angiogenesis in age-related macular degeneration.
Wang L; Lee AY; Wigg JP; Peshavariya H; Liu P; Zhang H
J Physiol Biochem; 2016 Dec; 72(4):583-592. PubMed ID: 27349759
[TBL] [Abstract][Full Text] [Related]
10. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
11. Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.
Siedlecki J; Wertheimer C; Wolf A; Liegl R; Priglinger C; Priglinger S; Eibl-Lindner K
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):963-972. PubMed ID: 28161830
[TBL] [Abstract][Full Text] [Related]
12. Recombinant humanized anti-vascular endothelial growth factor monoclonal antibody efficiently suppresses laser-induced choroidal neovascularization in rhesus monkeys.
Ji WW; Yu DA; Yang P; Fang P; Cao YX; Li H; Xie N; Yan SS
Eur J Pharm Sci; 2017 Nov; 109():624-630. PubMed ID: 28916483
[TBL] [Abstract][Full Text] [Related]
13. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
Lu X; Sun X
Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
[TBL] [Abstract][Full Text] [Related]
14. A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.
Toledano S; Lu H; Palacio A; Ziv K; Kessler O; Schaal S; Neufeld G; Barak Y
PLoS One; 2016; 11(12):e0168122. PubMed ID: 28036336
[TBL] [Abstract][Full Text] [Related]
15. An anti-PLVAP antibody suppresses laser-induced choroidal neovascularization in monkeys.
Nakagami Y; Hatano E; Chayama Y; Inoue T
Eur J Pharmacol; 2019 Jul; 854():240-246. PubMed ID: 31026444
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
17. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
Saravia M; Zeman L; Ingolotti M; Schlaen A
Med Hypotheses; 2017 Nov; 109():156-161. PubMed ID: 29150277
[TBL] [Abstract][Full Text] [Related]
18. Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models.
Giddabasappa A; Lalwani K; Norberg R; Gukasyan HJ; Paterson D; Schachar RA; Rittenhouse K; Klamerus K; Mosyak L; Eswaraka J
Exp Eye Res; 2016 Apr; 145():373-379. PubMed ID: 26927930
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
